Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a company based in China, has entered into a strategic partnership with the Haihe Laboratory of Cell Ecosystem under the China Academy of Medical Sciences. The collaboration aims to drive research translation, standardize disease diagnosis and treatment, advance digital healthcare, and enhance discipline construction, thereby promoting the clinical application of innovative technologies in the field of hematology diagnostics. Financial details of the agreement have not been disclosed.
Under the partnership, Dian Dx and the Haihe Laboratory of Cell Ecosystem will engage in joint clinical scientific research and establish a “precision medical diagnosis innovation research and development joint laboratory.” The collaboration will focus on facilitating the transformation and application of research outcomes. They also plan to develop standardized diagnosis and treatment protocols for related diseases, author and publish expert consensus and guidelines, and build a hierarchical diagnosis and treatment system.
Furthermore, the partners will explore new digital diagnostic and treatment technologies, promoting the integration of digital healthcare and artificial intelligence (AI) in disease diagnosis, treatment, and standardized management. The collaboration will also include talent exchange and cultivation, fostering multi-level and multidisciplinary development in the medical field.- Flcube.com
